Economic impact of delaying initiation with multiple-inhaler maintenance triple therapy in Spanish patients with chronic obstructive pulmonary disease

PURPOSE: Guidelines recommend the use of triple therapy with an inhaled corticosteroid (ICS), a long-acting β(2) agonist (LABA) and a long-acting muscarinic antagonist (LAMA) to reduce the risk of future exacerbations in symptomatic COPD patients with a history of exacerbations. This study aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Sicras Mainar, Antoni, Huerta, Alicia, Navarro Artieda, Ruth, Monsó, Eduard, Landis, Sarah H, Ismaila, Afisi S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748313/
https://www.ncbi.nlm.nih.gov/pubmed/31571848
http://dx.doi.org/10.2147/COPD.S211854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748313/
https://www.ncbi.nlm.nih.gov/pubmed/31571848
http://dx.doi.org/10.2147/COPD.S211854

Ejemplares similares